<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="119462">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02064270</url>
  </required_header>
  <id_info>
    <org_study_id>1208434</org_study_id>
    <nct_id>NCT02064270</nct_id>
  </id_info>
  <brief_title>A Study to Assess the Prevention of Postsurgical Incision Healing Complications in Patients Undergoing Primary or Revision Total Knee Arthroplasty (TKA) or Total Hip Arthroplasty (THA), Treated With Either Single-Use Negative Pressure Wound Therapy (NPWT) or Standard Postsurgical Dressings.</brief_title>
  <acronym>PICO</acronym>
  <official_title>A Prospective, Randomized, Controlled Clinical Study to Assess the Prevention of Postsurgical Incision Healing Complications in Patients Undergoing Primary or Revision Total Knee Arthroplasty (TKA) or Total Hip Arthroplasty (THA), Treated With Either Single-Use Negative Pressure Wound Therapy (NPWT) or Standard Postsurgical Dressings.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Missouri-Columbia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Smith &amp; Nephew, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Missouri-Columbia</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to assess the prevention of incision healing complications in
      patients undergoing TKA and THA treated with either Single-Use Incisional NPWT (Negative
      Pressure Wound Therapy), or standard of care dressings.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2014</start_date>
  <primary_completion_date type="Anticipated">January 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Incision appearance based on VAS (incision healing assessment form)</measure>
    <time_frame>35 days (+/- 14 days)</time_frame>
    <safety_issue>No</safety_issue>
    <description>VAS Scale: PICO Study Incision Healing Assessment Form. Used to represent the assessment of incision healing based on in-person visual appearance, or appearance based on standard digital photograph.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Drainage amount</measure>
    <time_frame>35 days (+/- 14 days)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Incision Drainage:
None
Slight (barely noticed)
Moderate (significant amount, but did not have to change dressing)
Extensive (had to change dressing)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>User-friendliness for patient</measure>
    <time_frame>7 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>User-Friendliness of PICO device:
Easy to use (no difficulties, no instruction needed)
Slightly difficult (needed instruction)
Minor difficulties (but able to use effectively)
Difficult (not able to use effectively)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>35 days (+/- 14 days)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Complications experienced by the subject within the study period time-frame will be recorded.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Return to the operating room</measure>
    <time_frame>35 days (+/- 14 days)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Information regarding the subject returning to the operating room within the research study time-frame will be recorded.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for antibiotics</measure>
    <time_frame>35 days (+/- 14 days)</time_frame>
    <safety_issue>No</safety_issue>
    <description>The need for additional antibiotics will be recorded.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Total Knee Arthroplasty (TKA) Incision</condition>
  <condition>Total Hip Arthroplasty (THA) Incision</condition>
  <arm_group>
    <arm_group_label>Single-Use Negative Pressure Wound Therapy (NPWT)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Single-Use Negative Pressure Wound Therapy (NPWT)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard postsurgical dressings</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard postsurgical dressings</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Single-Use Negative Pressure Wound Therapy (NPWT)</intervention_name>
    <arm_group_label>Single-Use Negative Pressure Wound Therapy (NPWT)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Standard postsurgical dressings</intervention_name>
    <arm_group_label>Standard postsurgical dressings</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. - Patient â‰¥18 years old

          2. - Male or non-pregnant females

          3. - Patient is scheduled to have a surgical procedure for Total Knee Arthroplasty or
             Total Hip Arthroplasty (Primary or Revision Procedure)

          4. - The patient is able to understand the trial and is willing to consent to the trial

        Exclusion Criteria:

          1. - Patients who in the opinion of the investigator may not complete the study for any
             reason

          2. - Patients with a known history of poor compliance with medical treatment

          3. - Patients who have participated in this trial previously and who were withdrawn

          4. - Patients with known allergies to product components (silicone adhesives and
             polyurethane films (direct contact with wound), acrylic adhesives (direct contact
             with skin), polyethylene fabrics and super-absorbent powders (polyacrylates) (within
             the dressing)

          5. - Patients not capable of obtaining a standardized digital picture at day 7 (1 week
             from surgery), and submitting it to the site.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Missouri Health System</name>
      <address>
        <city>Columbia</city>
        <state>Missouri</state>
        <zip>65212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James Stannard, MD</last_name>
      <phone>573-882-7189</phone>
    </contact>
    <investigator>
      <last_name>Thomas Aleto, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ajay Aggarwal, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bhajanjit Bal, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>James Cook, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 16, 2014</lastchanged_date>
  <firstreceived_date>February 6, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Missouri-Columbia</investigator_affiliation>
    <investigator_full_name>James Stannard</investigator_full_name>
    <investigator_title>Medical Director, Missouri Orthopaedic Institute; Chairman, Department of Orthopaedic Surgery</investigator_title>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
